Metabolic and Nonmetabolic Functions of PSAT1 Coordinate Signaling Cascades to Confer EGFR Inhibitor Resistance and Drive Progression in Lung Adenocarcinoma.
Ming-Yu LuoYe ZhouWei-Ming GuCheng WangNing-Xiang ShenJiang-Kai DongHui-Min LeiYa-Bin TangQian LiangJing-Hua ZouLu XuPengfei MaGuanglei ZhuangLing BiLing XuLiang ZhuHong-Zhuan ChenYing ShenPublished in: Cancer research (2022)
Metabolic and nonmetabolic functions of PSAT1 confer EGFR inhibitor resistance and promote metastasis in lung adenocarcinoma, suggesting therapeutic targeting of PSAT1 may attenuate the malignant features of lung cancer.